We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.88B
AUM Growth
-$312M
Cap. Flow
-$314M
Cap. Flow %
-16.69%
Top 10 Hldgs %
23.69%
Holding
207
New
35
Increased
64
Reduced
46
Closed
62

Top Buys

Rank Stock Value
1
ADM icon
Archer Daniels Midland
ADM
+$35.4M
2
SNX icon
TD Synnex
SNX
+$24M
3
MMM icon
3M
MMM
+$23.6M
4
MLCO icon
Melco Resorts & Entertainment
MLCO
+$17.8M
5
OPLN
Openlane
OPLN
+$16.9M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$37.1M
2
CMCSA icon
Comcast
CMCSA
+$36.9M
3
ILMN icon
Illumina
ILMN
+$32.3M
4
C icon
Citigroup
C
+$29.7M
5
VTRS icon
Viatris
VTRS
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 20.32%
2 Consumer Discretionary 17.17%
3 Energy 12.32%
4 Healthcare 9.35%
5 Consumer Staples 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEE icon
51
Ameren
AEE
$29.6B
$14.4M 0.76%
194,200
-9,534
-5% -$678K
TRIP icon
52
TripAdvisor
TRIP
$1.26B
$14.1M 0.75%
506,484
-57,076
-10% -$1.39M
SEE
53
DELISTED
Sealed Air
SEE
$13.8M 0.73%
370,045
+182,903
+98% +$6.56M
HSII
54
DELISTED
Heidrick & Struggles
HSII
$13.1M 0.7%
389,950
+93,400
+31% +$2.83M
CPA icon
55
Copa Holdings
CPA
$5.58B
$12.8M 0.68%
123,303
+6,503
+6% +$646K
BG icon
56
Bunge Global
BG
$21.6B
$12.3M 0.65%
+119,932
New +$11.2M
AMN icon
57
AMN Healthcare
AMN
$1.42B
$11.9M 0.63%
+190,924
New +$13M
UPWK icon
58
Upwork
UPWK
$1.21B
$11.8M 0.63%
964,641
+549,733
+132% +$7.48M
ALIT icon
59
Alight
ALIT
$394M
$11.4M 0.61%
57,946
+9,489
+20% +$1.72M
HAIN icon
60
Hain Celestial
HAIN
$53.4M
$11.3M 0.6%
+1,436,949
New +$14.2M
WHR icon
61
Whirlpool
WHR
$2.75B
$11M 0.58%
91,697
+64,142
+233% +$7.15M
LYFT icon
62
Lyft
LYFT
$6.55B
$10.4M 0.55%
535,015
-1,447,230
-73% -$22.2M
NVST icon
63
Envista
NVST
$4.53B
$10.3M 0.55%
481,558
+96,090
+25% +$2.18M
AVD icon
64
American Vanguard Corp
AVD
$65.5M
$10.3M 0.55%
792,181
-84,527
-10% -$927K
STT icon
65
State Street
STT
$51.3B
$10.1M 0.54%
+131,181
New +$9.73M
ABM icon
66
ABM Industries
ABM
$2.81B
$10.1M 0.54%
+225,695
New +$9.46M
DMC
67
Del Monte Corp
DMC
$1.43B
$9.99M 0.53%
385,584
+40,609
+12% +$1.01M
EQX icon
68
Equinox Gold
EQX
$13.5B
$9.87M 0.53%
1,640,220
-66,439
-4% -$308K
MD icon
69
Pediatrix Medical
MD
$2.12B
$9.76M 0.52%
972,849
-405,102
-29% -$3.77M
MTB icon
70
M&T Bank
MTB
$36.3B
$9.48M 0.5%
+65,173
New +$9.03M
SEAT icon
71
Vivid Seats
SEAT
$82.6M
$9.22M 0.49%
76,960
+57,194
+289% +$6.71M
YEXT icon
72
Yext
YEXT
$577M
$9.07M 0.48%
1,503,960
+603,598
+67% +$3.57M
MATV icon
73
Mativ Holdings
MATV
$706M
$9.05M 0.48%
482,542
-51,068
-10% -$762K
FVRR icon
74
Fiverr
FVRR
$327M
$8.58M 0.46%
407,361
+71,265
+21% +$1.78M
EPD icon
75
Enterprise Products Partners
EPD
$82.2B
$8.33M 0.44%
+285,357
New +$7.83M
1 2
3
4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Invenomic Capital Management held 207 positions worth $1.88B, down 14% from $2.19B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Invenomic Capital Management withdrew a net $314M in Q1 2024, closing 62 positions and reducing 46 holdings. Its most notable exit was QuidelOrtho, an estimated $37.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, Invenomic Capital Management opened a new position in Archer Daniels Midland worth $37.9M.

  • Invenomic Capital Management's largest Q1 2024 buy was Archer Daniels Midland: 603,681 shares worth $37.9M.
  • Invenomic Capital Management added most to 3M in Q1 2024, an estimated $23.6M increase.
  • Invenomic Capital Management's biggest Q1 2024 reduction was Illumina, cutting an estimated $32.3M.
  • Invenomic Capital Management fully exited QuidelOrtho in Q1 2024, selling an estimated $37.1M.
  • Invenomic Capital Management's ten largest holdings make up 24% of its $1.88B portfolio in Q1 2024.
  • Invenomic Capital Management opened 35 new positions and closed 62 in Q1 2024.
  • Invenomic Capital Management's portfolio value fell 14% quarter-over-quarter to $1.88B.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.